AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06574685 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Twinkle Eyez Supplementation
Description: The intervention supplement consisted of marigold extract, zeaxanthin, elderberry extract, bilberry extract, lycopene extract, multivitamin, silicon dioxide, inulin, and dextrose monohydrate, all in powder form and packaged in individual sachets (Twinkle Eyez™; Xmegami, Selangor, Malaysia). Each sachet contained 4.6 mg of lutein and zeaxanthin and 15.4 mg of elderberry extract.
Study NCT06574685 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The placebo supplement was identical in composition but excluded the active ingredients.
Study NCT06576180 — intervention group
Intervention type: DRUG
Intervention: Carboplatin（ neoadjuvant）
Description: Carboplatin (IV), AUC=5，administered by intravenous (IV) infusion on Day 1 of each 21-day cycle
Study NCT06576180 — intervention group
Intervention type: DRUG
Intervention: Paclitaxel （neoadjuvant）
Description: Paclitaxel 260mg/m2 administered by intravenous (IV) infusion on Day 1 of each 21-day cycle
Study NCT06576180 — intervention group
Intervention type: DRUG
Intervention: Anti-PD-1 Drugs
Description: Anti-PD-1 Drugs 200 mg administered by intravenous (IV) infusion on Day 1 of each 21-day cycle
Study NCT06576180 — intervention group
Intervention type: PROCEDURE
Intervention: Surgical resection
Description: Standard of care
Study NCT05219591 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: EPR
Description: application of EPR technology during CPAP treatment
Study NCT05510479 — intervention group
Intervention type: OTHER
Intervention: Software as medical device
Description: At home measurements of visual acuity through a mobile app
Study NCT05203341 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo tablets
Study NCT05206006 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: routine care
Description: The choice of the initial antibiotic regimen will be let to the discretion of the emergency physician
Study NCT05203341 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NBI-1065845
Description: NBI-1065845 tablets
Study NCT05457608 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lens A
Description: monthly replacement multifocal silicone hydrogel contact lens 15 minutes of daily wear
Study NCT05457608 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lens B
Description: daily disposable multifocal silicone hydrogel contact lens 15 minutes of daily wear
Study NCT05206006 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Computerized Decision support app (CDSA)
Description: Implementation of an Computerized Decision support app (CDSA) : physician will use this app to help him in the antibiotic choice. This app is an interactive algorithm based on international guidelines that takes into account patients' medical history and characteristics. Secondly, the application is also designed to propose an algorithm of antibiotic revaluation at day 3 for hospitalized patients, depending on patient clinical course, and biological and microbiological results. The revaluation suggests antimicrobial modification (escalation or de-escalation) or discontinuation and stopping rules with recommended duration of therapy also based on international guidelines.
Study NCT04826354 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rosuvastatin and Ezetimibe
Description: Rosuvastatin Versus Rosuvastatin plus Ezetimibe
Study NCT04826354 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Description: Rosuvastatin
Study NCT05484674 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Deroofing and laser
Description: Deroofing and laser to axilla
Study NCT04874870 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Collagenase Clostridium Histolyticum 0.9 MG [Xiaflex]
Description: 1 injection of 0.58mg will be injected into applicable cord.
Study NCT04874870 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Xiaflex + Hand-Based Custom Orthosis
Description: 1 injection of 0.58mg will be injected into applicable cord followed by use of hand-based custom orthosis to maintain finger extension
Study NCT06382350 — intervention group
Intervention type: DEVICE
Intervention: MiniMed 780 G
Description: none, observational study
Study NCT05538624 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AVB-001 (Dose Escalation Phase)
Description: One of four ascending doses of AVB-001 planned for IP, single dose administration in each dose level cohort of the Dose Escalation Phase (Part 1).
Study NCT05538624 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AVB-001 (Dose Expansion Phase)
Description: The MTD/RP2D as determined in the Dose Escalation Phase will be further evaluated in the Dose Expansion Phase.
Study NCT06356064 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy
Description: Radİal ESWT and focus ESWT
Study NCT05224050 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Smoking Cessation
Description: Participants will be provided with six individualized smoking cessation counseling sessions designed to help them prepare to quit, set a quit date, behaviorally manage early abstinence, and to resume cessation upon lapse.
Study NCT05224050 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Heart Rate Variability Biofeedback
Description: Participants will be provided with seven individualized trainings in resonance breathing using biofeedback to help improve self-regulation.
Study NCT05224050 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotine patch
Description: All participants will be offered up to eight weeks of transdermal nicotine patch, beginning on their quit date.
Study NCT05027451 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IXT-m200
Description: Anti-methamphetamine chimeric monoclonal antibody (mAb)
Study NCT05027451 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Normal saline
Study NCT06573463 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Prefabricated band and loop
Description: Prefabricated space maintainer requires only one visit as it fits into the patient's mouth at the clinic without needing the dental lab. It comes in a kit with different band sizes.
Study NCT06573463 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Band and loop
Description: Conventional band and loop is the most widely used space maintainer, It shows high success rate and good patient compliance, but needs more than one visit due to the laboratory work.
Study NCT06224647 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mobile Transdiagnostic Emotion Regulation Intervention
Description: The intervention aims to provide a tailored and engaging way for users to manage and comprehend their emotional well-being.~It consist of 5 components:~1. Daily tracking of emotions~2. A suite of exercises placed in six categories facilitating adaptive emotion regulation skills (i.e., upregulation of positive effect, self-compassion, cognitive defusion and cognitive restructuring, mindfulness, breathing techniques),~3. A self-assessment module where users can complete surveys evaluating their states (e.g., wellbeing) and traits (e.g., perfectionistic tendencies),~4. A personal toolkit area (i.e., each exercise is represented by an object commonly found in a student's room. Users can collect objects of favoured exercises in the virtual ROOM, enabling them quick access to exercises they liked / found helpful),~5. A recommendation system linking users to the content based on their specific needs or preferences
Study NCT05587595 — intervention group
Intervention type: OTHER
Intervention: questionnaires & data collection
Description: questionnaires
Study NCT04200989 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Peanut allergen
Description: Intralymphatic immunotherapy injections.
Study NCT04471194 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Self-sampling HPV test
Description: Tests for human papillomavirus from cervical cell sample
Study NCT04471194 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Fecal occult blood test
Description: Tests for human hemoglobin from blood in fecal samples
Study NCT05530434 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: transpulmonary pressure guided positive end expiratory pressure
Description: Positive end expiratory pressure will be titrated to achieve a transpulmonary pressure of 0-2 cm H2O
Study NCT05530434 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: standard positive end expiratory pressure
Description: Positive end expiratory pressure will be set to a standard 5-8 cm H2O by the clinician for spontaneous breathing trials
Study NCT05630833 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gepotidacin
Description: Gepotidacin will be administered.
Study NCT05630833 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nitrofurantoin
Description: Nitrofurantoin will be administered.
Study NCT05630833 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo will be administered.
Study NCT05630833 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Placebo will be administered.
Study NCT05457036 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Spry Belt
Description: The Spry Belt is a device worn around the hips which delivers gentle energy to the lower back. The level of energy is controlled by an internal microprocessor (computer) so that it is safe and comfortable. The energy is at a level that may or may not be perceptible to the user. The device is powered by an internal lithium-ion battery which must be recharged periodically. The device is designed to be used with its companion Spry app (via Bluetooth Low Energy (BLE)) so that anonymous usage statistics may be monitored. The expected shelf life of the device is longer than 2 years and the expected use life is at least 12-18 months.
Study NCT05457036 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Spry Belt
Description: The Sham Spry Belt is a device worn around the hips which does not deliver gentle energy to the lower back. The device instead provides a clicking noise similar to a motor. The device is powered by an internal lithium-ion battery which must be recharged periodically. The device is designed to be used with its companion Spry app (via BLE) so that anonymous usage statistics may be monitored. The expected shelf life of the device is longer than 2 years and the expected use life is at least 12-18 months.
Study NCT06358547 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: PGT-A
Description: PGT-A is a technique that allows for the prediction of embryo ploidy status through analysis of a trophectoderm biopsy conducted prior to embryo transfer.
Study NCT06209723 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Vegetarian diet
Description: Participants will follow a vegetarian diet during a period of five weeks
Study NCT04972552 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: coenzyme Q10
Description: Participants will take 800-1200 mg of coenzyme Q10 capsule per day
Study NCT04972552 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Watermelon diet
Description: Participants will be asked to eat watermelon at a minimum of one meal per day 3-5 days a week
Study NCT04972552 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Watermelon diet
Description: Participants will be asked to eat watermelon at a minimum of one meal per day 3-5 days a week
Study NCT04972552 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Diet
Description: Participants will be asked to eat a usual diet but not eat any watermelon as part of their usual diet
Study NCT04972552 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Usual Diet
Description: Participants will be asked to eat a usual diet but not eat any watermelon as part of their usual diet
Study NCT04972552 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will be asked to take 800-1200 mg of a placebo capsule per day
Study NCT06270004 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: nonsurgical periodontal therapy
Description: sonic scaler for scaling and polishing. Graces curettes numbers(1-2,3-4,5-6,7-8,9-10,11-12,13-14)for root surfaces debridement(RSD), instructions and motivation for dental arch
Study NCT05076578 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Autologous Regeneration of Tissue (ARTTM) system
Description: The ART Skin Harvesting System is intended to harvest full thickness skin microcolumns in a minimally invasive manner and scatter them at the recipient site. It consists of three components: (1) a non-sterile, reusable handheld device; (2) a sterile, single-patient use needle cartridge containing the needle array for harvesting skin micrografts from the patient donor site; and (3) a sterile, disposable handheld protective sleeve to cover the handheld device (figure 1). The sterile sleeve reduces contamination of the reusable handheld device and provides a sterile barrier between the non-sterile handheld device and the patient.
Study NCT05664022 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Global postural reeducation
Description: The GPR involves a series of active gentle movements and postures aimed at realigning joints, stretching shortened muscles, and enhancing the contraction of antagonist's muscles, thus avoiding postural asymmetry.~The GPR method includes eight therapeutic postures, lying, sitting or standing, to be held for 15/20 minutes each. Postures can be variously combined during sessions. Postures are chosen on the basis of some parameters, such as the amount of pain, load capacity and age of the patient, and muscle chains to be stretched. to increase the standardization of treatment, it will be proposed only 2 or 3 postures.
Study NCT05664022 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Global postural reeducation
Description: The GPR involves a series of active gentle movements and postures aimed at realigning joints, stretching shortened muscles, and enhancing the contraction of antagonist's muscles, thus avoiding postural asymmetry.~The GPR method includes eight therapeutic postures, lying, sitting or standing, to be held for 15/20 minutes each. Postures can be variously combined during sessions. Postures are chosen on the basis of some parameters, such as the amount of pain, load capacity and age of the patient, and muscle chains to be stretched. to increase the standardization of treatment, it will be proposed only 2 or 3 postures.
Study NCT05984524 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Gamma-Music Based Intervention
Description: Gamma or Control lights with Music-Based Intervention for 8 week period
Study NCT05984524 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Gamma-Music Based Intervention
Description: Gamma or Control lights with Music-Based Intervention for 8 week period
Study NCT04931732 — intervention group
Intervention type: BIOLOGICAL
Intervention: ctDNA analysis
Description: ctDNA analysis of patients with suspected primary glioma tumors and in patients with suspected recurrence.
Study NCT05486182 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 18F Fluoroestradiol Radiopharmaceutical with PET/CT
Description: Administration of one dose of 18F FES for PET/CT imaging
Study NCT04640376 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paracetamol Uniflash 125mg
Description: Oromucosal solution 1.25 mL for buccal use
Study NCT04640376 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Panadol 500 MG Oral Tablet X1
Description: Tablet masked in capsule
Study NCT04640376 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Panadol 500 MG Oral Tablet X2
Description: Tablet masked in capsule
Study NCT04640376 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Dummy treatment
Study NCT06182202 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Powered Prosthesis
Description: Custom in-house powered prosthetic device (used in prior studies, see Citations).
Study NCT04741750 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Simplified HCV care within a mobile medical unit
Description: Delivers guideline-based care for HCV in a stream-lined manner on a mobile medical unit
Study NCT05280444 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Idarubicin Hydrochloride for Injection
Description: The initial dose of idarubicin is 10 mg and the maximum tolerated dose is 20 mg. Idarubicin is first dissolved in water for injection to make a solvent of 2mg/ml, which is then mixed with lipiodol to make an emulsion with a ratio of 1:2. Lipiodol-idarubicin emulsion is slowly injected, followed by embolization with embolic agents.
Study NCT05419219 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: the multi-domain Tai Chi Digital therapy Software Application
Description: regular Tai Chi exercise, 40 Hz gamma sound stimulation and 18 BPM breath control exercise
Study NCT05419219 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: the multi-domain Tai Chi Digital therapy Software Application
Description: regular Tai Chi exercise, 40 Hz gamma sound stimulation and 18 BPM breath control exercise
Study NCT06430567 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Blood flow restriction (50% AOP compression) in the rehabilitation phase after Latarjet surgery for chronic shoulder instability
Description: Participants undergoing shoulder instability surgery (Latarjet procedure) by a single surgeon will receive standard physiotherapy (2 sessions per week) before being randomized into 3 groups at their 6th postoperative week check-up:~Group 1) BFR Group with 50% AOP compression~Group 1 will perform a 30-minute strengthening session twice weekly during postoperative weeks 7 to 14. They will do 4 exercises, completing 4 sets with 30-second rest intervals and 1 minute between exercises, following 30-15-15-15 at 40% 1RM (repetition maximum)~Exercise :~External rotation with pulley/band Internal rotation with pulley/band Frontal elevation with hyperpronation Diagonal abduction-external rotation with pulley/band~BFR training will use the MadUp© system, placing the band proximally on the operated arm, with a central unit continuously monitoring and calibrating arm pressure.
Study NCT06152562 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: VerifyNow antiplatelet therapy response test
Description: VerifyNow testing after minimum of 2 hours and at latest 24 hours after the first four dosis of ASA
Study NCT05356000 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Special low-oxalate diet followed by all-day visit to University of Chicago research clinic
Description: Active participation in this study will last for around one week. For the first two days, participants will be asked to eat a special diet at home. From Days 3-5, they will eat special meals that will be delivered to their home from a research clinic at the University of Chicago. They will also collect urine at home on Days 4 and 5.~On Day 6, subjects will come in to the research clinic at the University of Chicago in Hyde Park, where they will spend most of the day. They will receive a special liquid that contains oxalate, and will receive a specially prepared breakfast that is low in oxalate and citrate. After this, we will collect their urine and blood throughout the day. We will draw blood 4 separate times.
Study NCT05602844 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PSI Lapidus
Description: Design of PSI: DICOM files will be imported into the Model Intestinal Microflora in Computer Simulation (MIMICS 21.0) 3D image processing software (Materialize, Belgium) for 3D rendering. The segmented bone images will be used for design of the computer-aided modelling (CAM) surgical jigs. 3D printing of PSI jig. PSI-assisted Lapidus Surgery.
Study NCT05602844 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Lapidus
Description: exposure of the 1TMTJ via a 3-5cm medial longitudinal skin incision and capsulotomy. Freehand creation of the fusion surface with fluoroscopic assistance. Fixation of the Lapidus arthrodesis will be performed with two 3.5mm headless compression screws
Study NCT05552248 — intervention group
Intervention type: DEVICE
Intervention: LumbarBelt SOFT 300
Description: 15 patients will be included in this group and will used the medical device LumbarBelt SOFT 300 during sport practice (at least 2 sport sessions per week), for 12 weeks.
Study NCT05552248 — intervention group
Intervention type: OTHER
Intervention: Control group LumbarBelt SOFT 300
Description: 15 patients will be included in this control group and will performed their sport sessions as usual (without the medical device LumbarBelt SOFT 300), for at least 2 sport sessions per week during 12 weeks.
Study NCT05552248 — intervention group
Intervention type: DEVICE
Intervention: LumbarBelt MID 500
Description: 15 patients will be included in this group and will used the medical device LumbarBelt MID 500 during sport practice (at least 2 sport sessions per week), for 12 weeks.
Study NCT05552248 — intervention group
Intervention type: OTHER
Intervention: Control group LumbarBelt MID 500
Description: 15 patients will be included in this control group and will performed their sport sessions as usual (without the medical device LumbarBelt MID 500), for at least 2 sport sessions per week during 12 weeks.